$IBRX
ImmunityBio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is IBRX down today? It is at $7.82 (-3.81%), and our scanner flagged it 252 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IBRX spikes, and full due diligence on IBRX — key stats, earnings, dilution and insider activity. Free.
Get free $IBRX alerts the moment volume spikes
Our scanner flagged $IBRX 252 times in the last 30 days. Create a free account to track $IBRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $7.82
- Change today
- -3.81%
- Previous close
- $8.13
- 52-week range
- $1.95 – $12.43
- Market cap
- $8.18B
- Institutional own.
- 22.24%
- Total held
- 93.6%
- Tradeable float
- 67.4M 6% of shares · after 71% insiders + 22% institutions
- Short interest
- 129.0M ▼ -4% vs prior · as of 2026-07-31
- Days to cover
- 14.5d
- Avg daily volume
- 18.3M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 0.4x
- 15mthin
- 0.1x
- 1hthin
- 0.1x
- 1D
- 0.2x
Get free IBRX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $IBRX down today?
IBRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on IBRX today, peaking at 12.1x its normal volume.
Likely catalystImmunityBio, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13D/AActivist 5%+ stake updatedAug 6, 2026 · 14 days agoInsiders
Insiders selling0 buys, 6 sells last 3 months (1/24 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cohen Cheryl Director | Sold (automatic/other) | -131K 0.01% of company | sold 51% | 125K | $1.2M at $9.50 | Jul 2, 26 |
Cohen Cheryl Director | Other | 56K | added 28% | 257K | $167K at $2.98 | Jul 2, 26 |
Selecky Christobel Director | Sold (automatic/other) | -159K 0.02% of company | n/a | n/a | $1.4M at $9.02 | Jul 1, 26 |
Selecky Christobel Director | Other | 159K 0.02% of company | n/a | 159K | $475K at $2.98 | Jul 1, 26 |
Selecky Christobel Director | Sold (automatic/other) | -1K | n/a | n/a | $9K at $9.00 | Jun 30, 26 |
Selecky Christobel Director | Other | 1K | n/a | 1K | $3K at $2.98 | Jun 30, 26 |
Selecky Christobel Director | Sold (automatic/other) | -96K | n/a | n/a | $862K at $9.01 | Jun 29, 26 |
Selecky Christobel Director | Other | 96K | n/a | 96K | $272K at $2.84 | Jun 29, 26 |
Simon Barry J. Director | Sold (automatic/other) | -25K | sold 0.9% | 2.80M | $197K at $7.88 | Jun 24, 26 |
Simon Barry J. Director | Sold (automatic/other) | -23K | sold 0.8% | 2.83M | $165K at $7.18 | Jun 4, 26 |
Soon-Shiong Patrick Officer | Acquired (grant/award) | +4.61M 0.4% of company | added 0.7% | 624.85M | $25.0M at $5.43 | Mar 31, 26 |
Simon Barry J. Director | Sold (automatic/other) | -75K | sold 2.6% | 2.85M | $901K at $12.01 | Feb 24, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $IBRX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 202,631,048 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $460.0M in size · Priced at $2.27/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$IBRX Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$IBRX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to IBRX
Comparable names in biological products, (no diagnostic substances), closest in size first.
IBRX stock FAQ
Why is $IBRX down today?
IBRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on IBRX today, peaking at 12.1x its normal volume.
What is the IBRX stock price today?
IBRX last traded at $7.82, down 3.81% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live IBRX alerts?
The IBRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IBRX 252 times in the last 30 days.
What exchange is IBRX on?
IBRX (ImmunityBio, Inc. Common Stock) trades on XNAS, with a market cap of about $8.18B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is IBRX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IBRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.